US 12343394
CD38 modulating antibody agents
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 12343394 (CD38 modulating antibody agents) held by BLACK BELT THERAPEUTICS LIMITED expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BLACK BELT THERAPEUTICS LIMITED
- Grant date
- Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00